FundedIQ
Health Care

Selkirk Pharma: Funding, Investors & Team (Oct 2026)

Selkirk Pharma serves as a contract manufacturing organization (CMO) within the pharmaceutical sector. Comprised of knowledgeable professionals with extensive experience in parenteral manufacturing, they offer a wide range of expertise in engineering, operations, quality assurance, regulatory affairs, and laboratory services. The state-of-the-art facility they operate is specifically crafted to provide top-notch, efficient, and affordable aseptic manufacturing services of utmost quality.

www.selkirkpharma.com LinkedIn Spokane, United States 51-100 employees
Health Care Manufacturing Medical Pharmaceutical B2B
Total raised
$24.1M
Rounds
1
Latest
Undisclosed round
Sep 2023

Selkirk Pharma has raised $24.1M across 1 funding round on record, the most recent an undisclosed round of $24.1M announced in Sep 2023.

That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.

Selkirk Pharma Company Profile and Key Stats

Total funding raised
$24.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$24.1M in Sep 2023
Employees
51-100
reported band
Headquarters
Spokane, United States

Latest funding round on record: Sep 2023.

Selkirk Pharma Funding Rounds

Date
Round
Amount
Undisclosed round
$24.1M

Selkirk Pharma Founders and Leadership Team

Name
Role
Contact
Patrick Haffey
CEO
—

No contact details are on record for this team yet.

Selkirk Pharma Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,659
$4.9M
30,234
$7.6M

Selkirk Pharma's latest round of $24.1M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Selkirk Pharma in Health Care and Spokane

Companies Similar to Selkirk Pharma

Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…

Series A $25.0M

PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…

Undisclosed round $3.7M

General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…

Series B $120M

Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…

Series D $52.0M

SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…

Undisclosed round $4.0M

Aptatek is developing cutting edge technologies for portable disease management devices that will improve…

Undisclosed round —

Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…

Undisclosed round $150k

Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…

Undisclosed round $1.0M

For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…

Seed $250k

Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…

Undisclosed round $14.5M

Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…

Series B $14.9M

People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…

Undisclosed round $47.0M

Selkirk Pharma Funding FAQs

What does Selkirk Pharma do?

Selkirk Pharma serves as a contract manufacturing organization (CMO) within the pharmaceutical sector. Comprised of knowledgeable professionals with extensive experience in parenteral manufacturing, they offer a wide range of expertise in engineering, operations, quality assurance, regulatory affairs, and laboratory services. The state-of-the-art facility they operate is specifically crafted to provide top-notch, efficient, and affordable aseptic manufacturing services of utmost quality.

How much funding has Selkirk Pharma raised?

Selkirk Pharma has raised $24.1M across 1 round on record. The most recent is an undisclosed round of $24.1M announced in Sep 2023.

When did Selkirk Pharma last raise funding?

Selkirk Pharma's most recent funding round on record is an undisclosed round of $24.1M, announced in Sep 2023.

Who is the CEO of Selkirk Pharma?

Patrick Haffey is listed as CEO at Selkirk Pharma.

Where is Selkirk Pharma headquartered?

Selkirk Pharma is based in Spokane, Washington, United States.

How many employees does Selkirk Pharma have?

Selkirk Pharma is in the 51-100 employee band.

How does Selkirk Pharma's funding compare to other Health Care startups?

Selkirk Pharma's latest round of $24.1M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.

About FundedIQ's Selkirk Pharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Selkirk Pharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.